CH582144A5 - - Google Patents

Info

Publication number
CH582144A5
CH582144A5 CH707473A CH707473A CH582144A5 CH 582144 A5 CH582144 A5 CH 582144A5 CH 707473 A CH707473 A CH 707473A CH 707473 A CH707473 A CH 707473A CH 582144 A5 CH582144 A5 CH 582144A5
Authority
CH
Switzerland
Application number
CH707473A
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH582144A5 publication Critical patent/CH582144A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
CH707473A 1972-05-25 1973-05-17 CH582144A5 (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CH582144A5 true CH582144A5 (enrdf_load_html_response) 1976-11-30

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
CH707473A CH582144A5 (enrdf_load_html_response) 1972-05-25 1973-05-17

Country Status (12)

Country Link
JP (1) JPS4941367A (enrdf_load_html_response)
AT (1) AT323155B (enrdf_load_html_response)
AU (1) AU5607873A (enrdf_load_html_response)
BE (1) BE800066A (enrdf_load_html_response)
CA (1) CA1005062A (enrdf_load_html_response)
CH (1) CH582144A5 (enrdf_load_html_response)
CS (1) CS179416B2 (enrdf_load_html_response)
DD (1) DD106170A5 (enrdf_load_html_response)
DE (1) DE2226703A1 (enrdf_load_html_response)
FR (1) FR2185414B1 (enrdf_load_html_response)
GB (1) GB1436893A (enrdf_load_html_response)
NL (1) NL7307313A (enrdf_load_html_response)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
US7211599B2 (en) 2002-09-19 2007-05-01 The Regents Of The University Of California Use of etodolac to treat hyperplasia
CA2538759C (en) * 2003-09-12 2015-11-03 Elixir Pharmaceuticals, Inc. Substituted heterocyclic compounds as sirtuin inhitibitors
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
WO2005033112A2 (en) * 2003-10-02 2005-04-14 Cephalon, Inc. Substituted indole derivatives
PL2326621T3 (pl) * 2008-07-23 2016-12-30 Podstawione pochodne kwasu1,2,3,4-tetrahydrocyklopenta[b]indol- 3-ilo)octowego użyteczne w leczeniu zaburzeń autoimmunologicznych i zapalnych
CA2733671C (en) 2008-08-27 2018-01-02 Arena Pharmaceuticals, Inc. Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
ES2558087T3 (es) 2010-03-03 2016-02-01 Arena Pharmaceuticals, Inc. Procesos para la preparación de moduladores del receptor S1P1 y formas cristalinas de los mismos
FI3242666T3 (fi) 2015-01-06 2024-12-16 Arena Pharm Inc Menetelmiä s1p1-reseptoriin liittyvien sairauksien hoitamiseksi
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. S1p1 수용체-관련 장애에서의 사용을 위한 (r)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[b]인돌-3-일)아세트산 (화합물 1)의 결정성 l-아르기닌 염
US11478448B2 (en) 2017-02-16 2022-10-25 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法
CN112955431A (zh) 2018-09-06 2021-06-11 艾尼纳制药公司 可用于治疗自身免疫性病症和炎性病症的化合物
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586678A5 (enrdf_load_html_response) * 1970-05-25 1977-04-15 Hoffmann La Roche
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Also Published As

Publication number Publication date
AU5607873A (en) 1974-11-28
NL7307313A (enrdf_load_html_response) 1973-11-27
FR2185414A1 (enrdf_load_html_response) 1974-01-04
CA1005062A (en) 1977-02-08
BE800066A (fr) 1973-11-26
DD106170A5 (enrdf_load_html_response) 1974-06-05
AT323155B (de) 1975-06-25
DE2226703A1 (de) 1973-12-13
JPS4941367A (enrdf_load_html_response) 1974-04-18
CS179416B2 (en) 1977-10-31
FR2185414B1 (enrdf_load_html_response) 1976-08-13
GB1436893A (en) 1976-05-26

Similar Documents

Publication Publication Date Title
FR2185414B1 (enrdf_load_html_response)
FR2208210B1 (enrdf_load_html_response)
FR2177001B1 (enrdf_load_html_response)
JPS4953799A (enrdf_load_html_response)
JPS49584U (enrdf_load_html_response)
JPS4934046U (enrdf_load_html_response)
JPS4996029A (enrdf_load_html_response)
FR2181569B2 (enrdf_load_html_response)
JPS5613735Y2 (enrdf_load_html_response)
JPS48113557U (enrdf_load_html_response)
JPS4950503A (enrdf_load_html_response)
JPS4998703U (enrdf_load_html_response)
JPS4990851U (enrdf_load_html_response)
CH587302A5 (enrdf_load_html_response)
CH582683A5 (enrdf_load_html_response)
CH567620B5 (enrdf_load_html_response)
CH565427A5 (enrdf_load_html_response)
DD105188A5 (enrdf_load_html_response)
CH588561A5 (enrdf_load_html_response)
CH588148A5 (enrdf_load_html_response)
CH579326A5 (enrdf_load_html_response)
CH586934A5 (enrdf_load_html_response)
CH586685A5 (enrdf_load_html_response)
CH586498A5 (enrdf_load_html_response)
CH585280A5 (enrdf_load_html_response)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased